This compound is an active pharmaceutical ingredient (API) characterized by a complex heterocyclic structure containing multiple aromatic rings, ether groups, and a urea moiety. Its primary significance lies in its use as a pharmaceutical raw material for research and manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1884461-72-6
N-[2-[6,7-Dihydro-9,10-dimethoxy-4-oxo-2-[(2,4,6-trimethylphenyl)imino]-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl]ethyl]urea
active pharmaceutical ingredient
9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)3-(2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one
phosphodiesterase inhibitor
Eptifibatide
platelet aggregation inhibitor
(R)-N-Benzyl-1-(4-methoxyphenyl)propan-2-amine (S)-2-hydroxy-2-phenylacetate
active pharmaceutical ingredient
Streptozocin
antineoplastic agent and diabetogenic agent
4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-methylphenol
active pharmaceutical ingredient
2-(mesitylamino)-9,10-dimethoxy-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-4-one
research compound
2-[9,10-dimethoxy-4-oxo-2-(2,4,6-trimethylphenyl)imino-6,7-dihydropyrimido[6,1-a]isoquinolin-3-yl]ethylurea
CSOBIBXVIYAXFM-UHFFFAOYSA-N
CC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2CCNC(=O)N)OC)OC)C